U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C17H25N3O5.ClH
Molecular Weight 387.858
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ZOLEPRODOLOL HYDROCHLORIDE

SMILES

Cl.COC1=NOC(COC2=C(OCC(O)CNC(C)(C)C)C=CC=C2)=N1

InChI

InChIKey=IQEOUWNTUSFDSZ-UHFFFAOYSA-N
InChI=1S/C17H25N3O5.ClH/c1-17(2,3)18-9-12(21)10-23-13-7-5-6-8-14(13)24-11-15-19-16(22-4)20-25-15;/h5-8,12,18,21H,9-11H2,1-4H3;1H

HIDE SMILES / InChI

Description

Zoleprodolol was developed as an adrenoreceptor antagonist. Information about the current use of this compound is not available.

Approval Year

Unknown
149124
Name Type Language
ZOLEPRODOLOL HYDROCHLORIDE
Common Name English
PROXODOLOL
WHO-DD  
Preferred Name English
Proxodolol [WHO-DD]
Common Name English
5-(2-(3-TERT-BUTYLAMINO-2-HYDROXYPROPOXY)PHENOXYMETHYL)-3-METHYL-1,2,4-OXADIAZOLE HYDROCHLORIDE
Systematic Name English
2-PROPANOL, 1-((1,1-DIMETHYLETHYL)AMINO)-3-(2-((3-METHOXY-1,2,4-OXADIAZOL-5-YL)METHOXY)PHENOXY)-, HYDROCHLORIDE (1:1)
Systematic Name English
Code System Code Type Description
PUBCHEM
133046
Created by admin on Tue Apr 01 16:20:26 GMT 2025 , Edited by admin on Tue Apr 01 16:20:26 GMT 2025
PRIMARY
FDA UNII
87016Q25GZ
Created by admin on Tue Apr 01 16:20:26 GMT 2025 , Edited by admin on Tue Apr 01 16:20:26 GMT 2025
PRIMARY
EPA CompTox
DTXSID20935921
Created by admin on Tue Apr 01 16:20:26 GMT 2025 , Edited by admin on Tue Apr 01 16:20:26 GMT 2025
PRIMARY
CAS
158446-41-4
Created by admin on Tue Apr 01 16:20:26 GMT 2025 , Edited by admin on Tue Apr 01 16:20:26 GMT 2025
PRIMARY
ACTIVE MOIETY
Structure of ZOLEPRODOLOL
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966